The frequency of lingual tonsil enlargement in obese children

Carolina V A Guimaraes1, Maninder Kalra, Lane F Donnelly

  • 1Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 5031, Cincinnati, OH 45229-3039, USA.

Insights

Obese children frequently have enlarged lingual tonsils, especially after tonsillectomy. This finding suggests enlarged lingual tonsils may contribute to obstructive sleep apnea in this population.

Area of Science:

  • Pediatric Sleep Medicine
  • Otolaryngology
  • Radiology

Background:

  • Enlargement of lingual tonsils is an emerging cause of obstructive sleep apnea (OSA).
  • Obesity is a known risk factor for OSA.
  • The prevalence of enlarged lingual tonsils in obese children is not well-established.

Purpose of the Study:

  • To evaluate the frequency of enlarged lingual tonsils in obese children.
  • To compare lingual tonsil size in obese children with and without a history of tonsillectomy.

Main Methods:

  • Seventy-one obese children underwent MRI to measure lingual tonsil size.
  • Lingual tonsils > 10 mm were considered markedly enlarged.
  • Comparison between children with and without prior palatine tonsillectomy.

Main Results:

  • 62% of obese children had measurable lingual tonsils, a higher rate than previously reported.
  • 14% had markedly enlarged lingual tonsils (> 10 mm).
  • Children with prior tonsillectomy showed a significantly higher prevalence of enlarged lingual tonsils (78% vs. 22%) and markedly enlarged tonsils (90% vs. 10%).

Conclusions:

  • Obese children exhibit a high frequency of lingual tonsil enlargement.
  • Previous tonsillectomy is associated with a significantly higher prevalence of enlarged lingual tonsils in obese children.
  • Enlarged lingual tonsils may contribute to the development of obstructive sleep apnea in obese children.
Abstract

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...